Literature DB >> 12567274

Cytotoxic activity and G2/M cell cycle arrest mediated by antofine, a phenanthroindolizidine alkaloid isolated from Cynanchum paniculatum.

Sang Kook Lee1, Kyung-Ae Nam, Yoen-Hoi Heo.   

Abstract

Starting with an extract derived from the root of Cynanchum paniculatum Kitagawa (Asclepiadaceae) that was active in the process of inhibiting the growth of human cancer cells in culture, a phenanthroindolizidine alkaloid antofine was isolated and identified as an active principle (IC50 = 7.0 +/- 0.2 ng/ml for A549, human lung cancer cells; IC50 = 8.6 +/- 0.3 ng/ml for Col2, human colon cancer cells). Prompted by the high potency of cancer cell growth inhibition, additional action mechanism studies were performed with antofine. Utilizing cultured Col2 cells as a model, antofine induced arrest in the G2/M phase of the cell cycle after 48 h of incubation. With wash-out experiment, colony formation was also inhibited in a dose-dependent manner. These data suggest the potential of antofine to serve as a cancer chemotherapeutic agent by virtue of arresting the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12567274     DOI: 10.1055/s-2003-37021

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  14 in total

1.  Cytotoxic and anti-HIV phenanthroindolizidine alkaloids from Cryptocarya chinensis.

Authors:  Tian-Shung Wu; Chung-Ren Sun; Kuo-Hsiung Lee
Journal:  Nat Prod Commun       Date:  2012-06       Impact factor: 0.986

2.  Total syntheses of arylindolizidine alkaloids (+)-ipalbidine and (+)-antofine.

Authors:  Micah J Niphakis; Gunda I Georg
Journal:  J Org Chem       Date:  2010-09-03       Impact factor: 4.354

Review 3.  Applications of Friedel-Crafts reactions in total synthesis of natural products.

Authors:  Majid M Heravi; Vahideh Zadsirjan; Pegah Saedi; Tayebeh Momeni
Journal:  RSC Adv       Date:  2018-12-03       Impact factor: 4.036

4.  Total synthesis of phenanthroindolizidine alkaloids (+/-)-antofine, (+/-)-deoxypergularinine, and their dehydro congeners and evaluation of their cytotoxic activity.

Authors:  Chung-Ren Su; Amooru G Damu; Po-Cheng Chiang; Kenneth F Bastow; Susan L Morris-Natschke; Kuo-Hsiung Lee; Tian-Shung Wu
Journal:  Bioorg Med Chem       Date:  2008-04-18       Impact factor: 3.641

5.  Evaluation of medicated feeds with antiparasitical and immune-enhanced Chinese herbal medicines against Ichthyophthirius multifiliis in grass carp (Ctenopharyngodon idellus).

Authors:  De-Jie Lin; Ya-Nan Hua; Qi-Zhong Zhang; De-Hai Xu; Yao-Wu Fu; Yan-Meng Liu; Sheng-Yu Zhou
Journal:  Parasitol Res       Date:  2016-03-22       Impact factor: 2.289

6.  Synthesis, biological evaluation and mechanism studies of deoxytylophorinine and its derivatives as potential anticancer agents.

Authors:  Haining Lv; Jinhong Ren; Shuanggang Ma; Song Xu; Jing Qu; Zhenjia Liu; Qing Zhou; Xiaoguang Chen; Shishan Yu
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

7.  Synthesis and biological evaluation of carbocyclic analogues of pachastrissamine.

Authors:  Yongseok Kwon; Jayoung Song; Hoon Bae; Woo-Jung Kim; Joo-Youn Lee; Geun-Hee Han; Sang Kook Lee; Sanghee Kim
Journal:  Mar Drugs       Date:  2015-02-03       Impact factor: 5.118

8.  ANTI-VIRAL EFFECT OF HERBAL MEDICINE KOREAN TRADITIONAL CYNANCHUM PANICULATUM (BGE.) KITAG EXTRACTS.

Authors:  Woong Kim; Tae-Seok Oh; Youn-Jin Park
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-03-01

9.  Simultaneous determination of ten bioactive compaounds from the roots of Cynanchum paniculatum by using high performance liquid chromatography coupled-diode array detector.

Authors:  Jin Bae Weon; Bohyoung Lee; Bo-Ra Yun; Jiwoo Lee; Choong Je Ma
Journal:  Pharmacogn Mag       Date:  2012-07       Impact factor: 1.085

10.  In vitro anticancer effects of two novel phenanthroindolizidine alkaloid compounds on human colon and liver cancer cells.

Authors:  Jingjing Liu; Yu He; Dan Zhang; Ying Cai; Chenggang Zhang; Peng Zhang; Hongxia Zhu; Ningzhi Xu; Shufang Liang
Journal:  Mol Med Rep       Date:  2017-06-29       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.